Latest news: Vaccines authorized or under evaluation by EMA

Plenty of news regarding COVID-19 vaccines this week.

Plenty of news regarding COVID-19 vaccines this week.
March 4, 2021

Plenty of news regarding COVID-19 vaccines this week: on the one hand, today EMA announced that the Committee for Medicinal Products for Human Use (CHMP) has started a rolling review of Sputnik V (Gam-COVID-VAC) COVID-19 Vaccine. On the other hand, EMA also notified that the CHMP will hold an extraordinary meeting on the 11th of March in order to conclude the evaluation of the COVID-19 vaccine developed by Janssen-Cilag International N.V. If there is a positive outcome to this meeting, the evaluation process (which started with a rolling review on December 2020 and was followed by the conditional marketing authorisation evaluation on mid-February 2021) would be completed. If this vaccine is authorized, a total of 4 vaccines will be available on the European market, with three more on the way, already under EMA’s evaluation.

Asphalion is actively aiding in the development of new medicines to treat or prevent COVID-19. With each announcement of the authorization of new treatments and the hope they bring with them, we are sure that this development projects are worth each ounce of the invested effort.

For further information you can contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

RBDCOV | 14-months follow-up meeting

The second face-to-face RBDCOV meeting is taking place today at Palau Macaya in Barcelona! Our expert, Chris Mann, is attending the meeting in person. After

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting